NF-κB is thought to be an important driver of fibrosis and inflammation in NAFLD (91) and inactivation of NF-κB, in particular in Kupffer cells, protects against fibrosis in mice injected with CCl4 (60). Here, NFKB1 is linked to metabolic dysfunction-associated steatotic liver disease.